Kirsch Arthur S insider trades
Kirsch Arthur S has filed 14 Form 4s with the SEC that we hold, for Liquidia Corp (LQDA) (Director), Evommune, Inc. (EVMN) (Director), Atea Pharmaceuticals, Inc. (AVIR) (Director) and KDMN (Director). Across all of them we count 2 purchases worth $260.2K and 3 sales worth $1.7M reported on Form 4. In the last 12 months: 1 purchase ($133.0K) and 3 sales ($1.7M). The largest single trade was a sale of 15,000 shares of Liquidia Corp worth $903.3K, dated 2026-06-01. The first filing on our record is dated 2021-09-01 and the latest 2026-07-08.
Liquidia Corp (LQDA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-10 | P, purchase reported on Form 4 | 30,000 | $127.2K | 2021-11-12 |
| 2026-06-01 | S, sale reported on Form 4 | 15,000 | $903.3K | 2026-06-03 |
| 2026-06-02 | S, sale reported on Form 4 | 5,000 | $280.0K | 2026-06-03 |
| 2026-06-03 | S, sale reported on Form 4 | 10,000 | $548.0K | 2026-06-03 |
Evommune, Inc. (EVMN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-07-07 | P, purchase reported on Form 4 | 10,000 | $133.0K | 2026-07-08 |
Atea Pharmaceuticals, Inc. (AVIR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
KDMN
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1290976) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms